AstraZeneca
investing in new launches near and mid term pipeline phase trials initiated across medicines phase trials initiated with blockbuster potential regulatory approvals in major markets new medicines approved and on track to deliver on ambition for at least launches by | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
February 2024
Slide
8 of 45
Related slides by other companies
BioNTech
Results
August 2020
initiated phase trial for our agonist in | BioNTech
9 Meters Biopharma
Investor Presentation
September 2022
vibrant phase trial design meters | 9 Meters Biopharma
MindMed
Investor Presentation
November 2024
phase trial schematic schematic | MindMed
ATAI
Investor Presentation
March 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights